I wouldn't ignore him. He's actually right but being cryptic.
You are literally betting on whether the new reimbursement center improves the paid script ratios this quarter or not. Vials shipped in April is a bit of a vague statement.
Was it pharmacy restock, new paid scripts being filled, combination of both, or an anomaly.
One of the analysts did ask that on the CC. Answer really was that they didn't know but it seems a strong indicator for demand. Demand is up, as many long analysts here posted the last couple months. They have to get paid for them though, to see profit.
Place your bet, does the reimbursement center improve this quarter or not. Nothing else really matters at this point, does it?
Mikey...I would trust Deerfiled and Blackrock more than some random basher on YMB. He may or may not be right, but in any case I do know that QCOR is NOT a $ 35 stock. I guess we will find out in few months.